Vesper Bio

About:

Vesper Bio is a clinical-stage biotechnology company.

Website: https://www.vesperbio.com

Top Investors: Michael J. Fox Foundation

Description:

Vesper Bio is a clinical-stage biotechnology company that makes an observation that may enable the development of a cure/treatment against a devastating or fatal disorder.

Total Funding Amount:

$873000

Headquarters Location:

Copenhagen, Hovedstaden, Denmark

Founded Date:

2013-01-01

Contact Email:

info(AT)vesperbio.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-01-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai